Seeking Alpha

Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.59 beats by $0.02. Revenue of $51M (+45% Y/Y) in-line....

Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.59 beats by $0.02. Revenue of $51M (+45% Y/Y) in-line. Shares -0.38% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)